Financial News
Press Releases about Lexaria Bioscience Corp WT
Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study
November 14, 2024
Via ACCESSWIRE
Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments
November 07, 2024
Via ACCESSWIRE
Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
October 09, 2024
Via ACCESSWIRE
Via ACCESSWIRE
Lexaria Updates Current GLP-1 Market
October 08, 2024
Via ACCESSWIRE
Lexaria Appoints Michael Shankman as Chief Financial Officer
October 01, 2024
Via ACCESSWIRE
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Shares Letter from Outgoing CEO
September 06, 2024
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Lexaria Releases Strategic Letter from the Outgoing CEO
September 05, 2024
Via ACCESSWIRE
Lexaria Welcomes Industry Veteran as New CEO
September 05, 2024
Via ACCESSWIRE
First Results from Lexaria's Second GLP-1 Human Pilot Study
August 27, 2024
Via ACCESSWIRE
Lexaria Enters a Material Transfer Agreement for DehydraTECH Research
September 03, 2024
Via ACCESSWIRE
Positive Results from Lexaria's Molecular Characterization Study
August 19, 2024
Via ACCESSWIRE
Lexaria Preparing For Strategic Growth
July 16, 2024
Via ACCESSWIRE
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.